Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
ILMN [NASD]
Illumina Inc.
Index- P/E119.31 EPS (ttm)1.44 Insider Own1.30% Shs Outstand128.40M Perf Week3.39%
Market Cap22.06B Forward P/E64.08 EPS next Y2.68 Insider Trans-0.06% Shs Float126.68M Perf Month1.81%
Income207.90M PEG6.27 EPS next Q0.51 Inst Own- Short Float4.40% Perf Quarter13.26%
Sales1.51B P/S14.60 EPS this Y-20.40% Inst Trans-1.71% Short Ratio3.59 Perf Half Y19.22%
Book/sh12.28 P/B13.99 EPS next Y23.55% ROA7.10% Target Price182.00 Perf Year110.62%
Cash/sh8.50 P/C20.20 EPS next 5Y19.03% ROE14.20% 52W Range72.77 - 185.00 Perf YTD55.35%
Dividend- P/FCF89.16 EPS past 5Y24.60% ROI3.90% 52W High-6.43% Beta0.66
Dividend %- Quick Ratio1.30 Sales past 5Y19.90% Gross Margin64.30% 52W Low137.87% ATR6.29
Employees3000 Current Ratio1.40 Sales Q/Q27.10% Oper. Margin18.50% RSI (14)50.84 Volatility4.53% 3.54%
OptionableYes Debt/Eq0.63 EPS Q/Q322.20% Profit Margin13.80% Rel Volume0.80 Prev Close171.80
ShortableYes LT Debt/Eq0.09 EarningsJul 23 AMC Payout0.00% Avg Volume1.55M Price173.10
Recom2.20 SMA20-1.33% SMA503.09% SMA20025.94% Volume251,556 Change0.76%
24-Jul-14Reiterated Mizuho Buy $200 → $220
17-Jul-14Reiterated Maxim Group Buy $205 → $220
23-Apr-14Upgrade Maxim Group Hold → Buy $205
23-Apr-14Reiterated Mizuho Buy $175 → $200
23-Apr-14Reiterated ISI Group Neutral $152.50 → $162.50
19-Feb-14Reiterated UBS Buy $152 → $202
29-Jan-14Reiterated Mizuho Buy $150 → $175
29-Jan-14Reiterated ISI Group Neutral $134.50 → $147
17-Jan-14Reiterated Mizuho Buy $135 → $150
14-Jan-14Reiterated Mizuho Buy $125 → $135
19-Dec-13Reiterated Mizuho Buy $100 → $125
22-Oct-13Reiterated Mizuho Buy $86 → $100
22-Oct-13Reiterated Barclays Overweight $85 → $90
24-Jul-13Reiterated Mizuho Buy $83 → $86
24-Jul-13Reiterated ISI Group Neutral $75 → $78.50
23-Jul-13Reiterated UBS Buy $67 → $90
22-Jul-13Reiterated Barclays Overweight $55 → $80
23-Apr-13Reiterated UBS Buy $61 → $67
23-Apr-13Reiterated ISI Group Neutral $60 → $61.50
23-Apr-13Reiterated Cantor Fitzgerald Hold $48 → $53
24-Jul-14 05:07PM  Celgene, Alexion Beat Estimates, But Biotechs Fall at Investor's Business Daily
04:26PM  Stock Indexes Nearly Flat, But Apparel, Paper, Internet Shine at Investor's Business Daily
11:58AM  Under Armour, Facebook Soar As Nasdaq Turns Positive at Investor's Business Daily
11:00AM  Illumina (ILMN) Tops Q2 Earnings & Revenues, Ups Guidance Zacks
07:18AM  Illumina price target raised to $195 from $180 at Leerink theflyonthewall.com
23-Jul-14 05:00PM  Illumina Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:09PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2014 Business Wire
07:07AM  Q2 2014 Illumina, Inc. Earnings Release - After Market Close CCBN
22-Jul-14 09:52AM  Arks Wood Says Athena a Fall Through Cracks Stock (Audio) at Bloomberg
09:38AM  How A Giant Act Of Philanthropy May Kickstart Psychiatry at Forbes
07:45AM  Sidra to Help Qatar Grow as a Hub for Genetic Medicine Business Wire
21-Jul-14 01:33PM  Big Week of Earnings for Big Biotech ETF ETF Trends
06:30AM  Berry Genomics and Illumina Co-Develop Integrated Next-Generation Sequencing System for Review and Approval by Chinese Regulatory Agency Business Wire
03:05AM  5 Strong Stocks To Buy Before Earnings at Seeking Alpha
17-Jul-14 08:56AM  An Unsolicited Comment On Janet Yellen's Biotech Comments at Forbes
16-Jul-14 06:31AM  Illumina acquires Myraqa at theflyonthewall.com
06:30AM  Illumina Acquires Myraqa, a Leading IVD and Companion Diagnostic Consulting Firm Business Wire
14-Jul-14 04:08PM  Illumina Names Tina S. Nova As Senior Vice Pres And General Manager Of Oncology Benzinga
04:05PM  Illumina Names Tina S. Nova as Senior Vice President and General Manager of Oncology Business Wire
03:23PM  Is NanoString The Next Illumina In Cancer Diagnostics? at Seeking Alpha
10:38AM  5 Rocket Stocks to Buy for Summer Gains at TheStreet
12-Jul-14 12:00AM  England Asks Illumina to Map 100,000 Genomes at Bloomberg
11-Jul-14 06:03PM  England Asks Illumina to Map 100,000 Genomes at Bloomberg
10-Jul-14 06:43PM  Some Stock Leaders Stay Firm Amid Pullback at Investor's Business Daily
09-Jul-14 04:05PM  ILLUMINA INC Files SEC form 8-K, Other Events EDGAR Online
06:30AM  Illumina to Announce Second Quarter 2014 Financial Results on Wednesday, July 23, 2014 Business Wire
07-Jul-14 08:05PM  Qiagen Is Next Deal Candidate With Tax Allure: Real M&A at Bloomberg
06:16PM  Do Illumina and Incyte Belong in Your Portfolio? at Motley Fool
11:47AM  Albany Molecular's Oso Buy Seen Boosting Earnings at Investor's Business Daily
03-Jul-14 06:26PM  Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week at Investor's Business Daily
06:26PM  Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week at Investor's Business Daily
01-Jul-14 05:05PM  Illumina Expands in Europe on 3 NIPT Deals Zacks
03:23PM  Growth stocks are doing most bullish thing they can at MarketWatch
30-Jun-14 02:58PM  Stocks Mixed In Late Trade, But Growth Stocks Outperform at Investor's Business Daily
01:32PM  Nasdaq Showing Outperformance; GoPro Extends Gains at Investor's Business Daily
01:04PM  3 Stocks Pushing The Drugs Industry Higher at TheStreet
12:13PM  Midday movers: Allergan, MBIA, Treehouse Foods & More at CNBC
10:18AM  Illumina (ILMN) On Momo Momentum Watch Today at TheStreet
09:07AM  Illumina: 9 Different Insiders Have Sold Shares This Month at Seeking Alpha
03:01AM  Biomnis, Genoma, and the Center for Human Genetics and Laboratory Diagnostics Martinsried, Enter Agreements with Illumina to Expand Access for Non-Invasive Prenatal Testing Across Europe Business Wire
26-Jun-14 11:14AM  Must-See Charts: 5 Large-Caps to Trade for Gains
10:06AM  Sequenom: A Reversal Of Misfortune at Seeking Alpha
10:06AM  Sequenom: A Reversal Of Misfortune
25-Jun-14 06:28AM  Strength Seen in Vertex Pharmaceuticals Incorporated (VRTX) as Stock Shoots 40.41% Zacks
06:28AM  Strength Seen in Vertex Pharmaceuticals Incorporated (VRTX) as Stock Shoots 40.41%
24-Jun-14 02:12PM  Will Danaher Corporation Bounce Back With a Big Buyout?
23-Jun-14 02:00PM  3 Hot Biotech Stocks Hitting Highs
06:32AM  Strength Seen in Cara Therapeutics Inc. (CARA) as Stock Rallies 19.60%
20-Jun-14 01:30PM  Illumina: Updated Research Report Zacks
01:30PM  Illumina: Updated Research Report
11:20AM  Illumina (ILMN) Highlighted As Momo Momentum Stock at TheStreet
11:20AM  Illumina (ILMN) Highlighted As Momo Momentum Stock
19-Jun-14 07:27AM  Protalix (PLX) in Focus: Stock Adds 6.5% in Session Zacks
07:27AM  Protalix (PLX) in Focus: Stock Adds 6.5% in Session
06:42AM  China Biologic Products (CBPO) in Focus: Stock Plunges 11.4% Zacks
06:40AM  Intra-Cellular Therapies, Inc. (ITCI) in Focus: Stock Rises 8.74% Zacks
06:40AM  Intra-Cellular Therapies, Inc. (ITCI) in Focus: Stock Rises 8.74%
02:03AM  Acorda Therapeutics (ACOR) in Focus: Stock Moves 7.8% Higher Zacks
01:00AM  As sequencing moves into clinical use, insurers balk Reuters
18-Jun-14 08:16AM  AVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 11.4% Zacks
17-Jun-14 07:41AM  Orexigen (OREX) in Focus: Stock Moves 7.5% Higher Zacks
07:02AM  Achillion Pharmaceuticals (ACHN) Jumps: Stock Up 20.9% Zacks
16-Jun-14 06:52AM  What Falling Estimates & Price Mean for Rexahn Pharmaceuticals (RNN) Zacks
06:52AM  What Falling Estimates & Price Mean for Rexahn Pharmaceuticals (RNN)
06:46AM  Nektar Therapeutics (NKTR) in Focus: Stock Rises 10.77% Zacks
06:46AM  Nektar Therapeutics (NKTR) in Focus: Stock Rises 10.77%
13-Jun-14 07:15AM  BIND Therapeutics (BIND) Soars: Stock Up 6.8% Zacks
12-Jun-14 04:02PM  Genomic Health's Oncotype DX Redefines Breast Cancer Therapy Zacks
08:54AM  Will Illumina (ILMN) Continue to Surge Higher? Zacks
08:54AM  Will Illumina (ILMN) Continue to Surge Higher?
08:17AM  Vital Therapies (VTL) Catches Eye: Stock Surges 20.7% Zacks
08:17AM  Vital Therapies (VTL) Catches Eye: Stock Surges 20.7%
11-Jun-14 04:06PM  ILLUMINA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio EDGAR Online
04:06PM  ILLUMINA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio
06:46AM  Strength Seen in Receptos, Inc. (RCPT) as Stock Shoots up 36.78% Zacks
06:46AM  Strength Seen in Receptos, Inc. (RCPT) as Stock Shoots up 36.78%
06:39AM  Oragenics (OGEN) in Focus: Stock Adds 6% in Session Zacks
10-Jun-14 05:27PM  [video] Cool pharma tech at CNBC
05:00PM  Why did Halvorsens Viking Global boost its position in Illumina? Market Realist
02:40PM  Integra Lifesciences Down to Sell on Poor Q1 Segment Show Zacks
06:58AM  Fibrocell Science (FCSC) Jumps: Stock Rises 6.9% Zacks
06:31AM  AVEO Pharmaceuticals, Inc. (AVEO) in Focus: Stock Rises 7.8% Zacks
09-Jun-14 06:53PM  A Few Medical Research Stocks Break Out, Others Basing at Investor's Business Daily
09:47AM  Illumina Is Up 140% In The Past Year, But Can It Illuminate Your Portfolio Going Forward? at Seeking Alpha
06:45AM  Aerie Pharmaceuticals, Inc. (AERI) in Focus: Stock Rises 5.71% Zacks
06-Jun-14 02:49PM  Illumina Is How You Play Biotech Without Being in Biotech at TheStreet
01:03PM  3 Stocks Moving The Drugs Industry Upward at TheStreet
06:44AM  Celldex Therapeutics (CLDX) Soars: Stock Adds 12.6% in Session Zacks
06:30AM  Illumina Announces Pricing of Convertible Senior Notes Business Wire
05-Jun-14 03:05PM  Stocks Hold Near Highs; Illumina Breakout Gains Traction at Investor's Business Daily
01:28PM  Stocks Build On Gains Backed By Strong Volume at Investor's Business Daily
10:50AM  Unusual Social Activity Around Illumina (ILMN) Today at TheStreet
10:28AM  Stocks Reverse Into Thin Losses; Joy Global, Illumina Rocket at Investor's Business Daily
07:21AM  Progenics Pharmaceuticals (PGNX) in Focus: Stock Falls 5.5% Zacks
06:54AM  MannKind Corp. (MNKD) Soars: Stock Adds 10.8% in Session Zacks
04-Jun-14 04:15PM  Illumina files to sell $900M of convertible senior notes theflyonthewall.com
04:01PM  Illumina to Offer $900 Million Convertible Senior Notes Business Wire
01:46PM  Five Star Biotech Stock Watch: Illumina Benzinga
06:51AM  Amicus Therapeutics, Inc. (FOLD) in Focus: Stock Rises 8.13% Zacks
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company's products include sequencing platforms that are based on its SBS technology are designed to meet the various demands of a range of sequencing applications; and array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of array-based genetic analysis products. It also offers various sample preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping and whole genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRADBURY DANIELDirectorJul 23Option Exercise36.292,10076,20914,566Jul 24 07:43 PM
BRADBURY DANIELDirectorJul 23Sale177.872,100373,52312,466Jul 24 07:43 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJul 15Option Exercise53.1920,0001,063,80038,519Jul 16 09:28 PM
Naclerio NicholasSr VP, Corp DevelopmentJul 15Option Exercise43.372,00086,74025,146Jul 16 09:28 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJul 15Sale174.0920,0003,481,76528,519Jul 16 09:28 PM
Naclerio NicholasSr VP, Corp DevelopmentJul 15Sale174.262,000348,51123,146Jul 16 09:28 PM
Stapley MarcSr VP & CFOJul 14Option Exercise36.301,42251,61923,418Jul 15 07:32 PM
Stapley MarcSr VP & CFOJul 14Sale177.591,422252,53621,996Jul 15 07:32 PM
FLATLEY JAY TChief Executive OfficerJul 10Option Exercise20.0430,000601,200411,262Jul 11 07:09 PM
FLATLEY JAY TChief Executive OfficerJul 10Sale172.5630,0005,176,935381,262Jul 11 07:09 PM
BRADBURY DANIELDirectorJul 08Option Exercise36.292,10076,20914,566Jul 09 05:59 PM
BRADBURY DANIELDirectorJul 08Sale172.892,100363,07712,466Jul 09 05:59 PM
Bouchard MichelVP, Finance & Chief AccountingJul 01Option Exercise69.3463143,75424,821Jul 01 07:22 PM
Ronaghi MostafaSr VP & CTOJul 01Option Exercise44.3810,000443,80038,604Jul 01 07:21 PM
Naclerio NicholasSr VP, Corp DevelopmentJul 01Option Exercise69.3425,0001,733,50048,146Jul 01 07:29 PM
Ronaghi MostafaSr VP & CTOJul 01Sale179.4710,0001,794,70728,604Jul 01 07:21 PM
Naclerio NicholasSr VP, Corp DevelopmentJul 01Sale181.4225,0004,535,57723,146Jul 01 07:29 PM
Bouchard MichelVP, Finance & Chief AccountingJul 01Sale180.08631113,62924,190Jul 01 07:22 PM
MOELLER GERALDDirectorJun 30Option Exercise42.815,000214,05022,265Jul 01 07:22 PM
MOELLER GERALDDirectorJun 30Sale178.975,000894,83017,265Jul 01 07:22 PM
RASTETTER WILLIAM HDirectorJun 30Sale174.3433458,2305,687Jul 01 07:22 PM
BRADBURY DANIELDirectorJun 27Option Exercise36.292,10076,20914,566Jun 27 07:05 PM
Dadswell CharlesSr VP & General CounselJun 27Sale171.4419232,91642,749Jun 27 07:05 PM
BRADBURY DANIELDirectorJun 27Sale171.652,100360,45512,466Jun 27 07:05 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 16Option Exercise53.1920,0001,063,80038,519Jun 17 01:46 PM
Stapley MarcSr VP & CFOJun 16Option Exercise36.301,42251,61923,418Jun 17 01:45 PM
Naclerio NicholasSr VP, Corp Develop & GMJun 16Option Exercise43.372,00086,74025,146Jun 17 01:46 PM
Stapley MarcSr VP & CFOJun 16Sale169.251,422240,67221,996Jun 17 01:45 PM
Naclerio NicholasSr VP, Corp Develop & GMJun 16Sale169.802,000339,60123,146Jun 17 01:46 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 16Sale169.7320,0003,394,58328,519Jun 17 01:46 PM
BRADBURY DANIELDirectorJun 12Option Exercise36.292,10076,20914,566Jun 16 03:09 PM
FLATLEY JAY TChief Executive OfficerJun 12Option Exercise20.0430,000601,200411,262Jun 16 03:09 PM
BRADBURY DANIELDirectorJun 12Sale171.172,100359,45912,466Jun 16 03:09 PM
FLATLEY JAY TChief Executive OfficerJun 12Sale172.2530,0005,167,508381,262Jun 16 03:09 PM
EASTHAM KARINDirectorJun 02Option Exercise17.586,000105,45015,826Jun 03 08:06 PM
Bouchard MichelChief Accounting OfficerJun 02Option Exercise69.3463243,82325,681Jun 03 08:05 PM
Ronaghi MostafaSr VP & CTOJun 02Option Exercise44.3810,000443,80038,604Jun 03 08:06 PM
Naclerio NicholasSr VP, Corp Develop & GMJun 02Option Exercise43.3760,0002,602,20083,146Jun 03 08:20 PM
EASTHAM KARINDirectorJun 02Sale157.566,000945,3379,826Jun 03 08:06 PM
Bouchard MichelChief Accounting OfficerJun 02Sale155.511,491231,87024,190Jun 03 08:05 PM
Ronaghi MostafaSr VP & CTOJun 02Sale156.9310,0001,569,29228,604Jun 03 08:06 PM
Naclerio NicholasSr VP, Corp Develop & GMJun 02Sale157.6060,0009,455,93223,146Jun 03 08:20 PM
BRADBURY DANIELDirectorMay 27Option Exercise36.832,10077,34911,624May 29 06:47 PM
BRADBURY DANIELDirectorMay 27Sale159.042,100333,9879,924May 29 06:47 PM
FLATLEY JAY TChief Executive OfficerMay 22Option Exercise20.0430,000601,200411,262May 23 06:13 PM
FLATLEY JAY TChief Executive OfficerMay 22Sale154.9530,0004,648,479381,262May 23 06:13 PM
WHITFIELD ROY ADirectorMay 15Option Exercise19.614,00078,44013,196May 15 08:52 PM
Naclerio NicholasSr VP, Corp Develop & GMMay 15Option Exercise43.372,00086,74025,146May 15 08:53 PM
WHITFIELD ROY ADirectorMay 15Sale143.714,000574,8409,196May 15 08:52 PM
Naclerio NicholasSr VP, Corp Develop & GMMay 15Sale141.722,000283,44423,146May 15 08:53 PM
Stapley MarcSr VP & CFOMay 14Option Exercise36.301,42251,61923,418May 14 07:28 PM
BRADBURY DANIELDirectorMay 14Option Exercise39.142,10082,19412,024May 14 07:28 PM
Stapley MarcSr VP & CFOMay 14Sale146.941,422208,94821,996May 14 07:28 PM
BRADBURY DANIELDirectorMay 14Sale146.462,100307,5719,924May 14 07:28 PM
FLATLEY JAY TChief Executive OfficerMay 08Option Exercise20.0430,000601,200411,262May 12 08:10 PM
FLATLEY JAY TChief Executive OfficerMay 08Sale143.5930,0004,307,824381,262May 12 08:10 PM
BRADBURY DANIELDirectorMay 02Option Exercise39.142,10082,19412,024May 02 07:43 PM
BRADBURY DANIELDirectorMay 02Sale139.662,100293,2829,924May 02 07:43 PM
Ronaghi MostafaSr VP & CTOMay 01Option Exercise44.3810,000443,80038,604May 01 07:01 PM
Bouchard MichelChief Accounting OfficerMay 01Option Exercise69.3463143,75425,680May 01 07:01 PM
Ronaghi MostafaSr VP & CTOMay 01Sale135.9110,0001,359,13128,604May 01 07:01 PM
Bouchard MichelChief Accounting OfficerMay 01Sale135.8863185,74025,049May 01 07:01 PM
FLATLEY JAY TChief Executive OfficerApr 24Option Exercise20.0430,000601,200411,262Apr 25 06:00 PM
FLATLEY JAY TChief Executive OfficerApr 24Sale150.8030,0004,524,012381,262Apr 25 06:00 PM
RASTETTER WILLIAM HDirectorApr 21Sale135.82879119,3863,479Apr 22 07:12 PM
BRADBURY DANIELDirectorApr 15Option Exercise39.142,10082,19412,024Apr 16 08:03 PM
Naclerio NicholasSr VP, Corp Develop & GMApr 15Option Exercise43.372,00086,74025,146Apr 16 08:36 PM
BRADBURY DANIELDirectorApr 15Sale131.292,100275,7059,924Apr 16 08:03 PM
Naclerio NicholasSr VP, Corp Develop & GMApr 15Sale133.562,000267,11323,146Apr 16 08:36 PM
Stapley MarcSr VP & CFOApr 14Option Exercise36.301,42251,61923,418Apr 14 09:15 PM
Stapley MarcSr VP & CFOApr 14Sale134.801,422191,69121,996Apr 14 09:15 PM
FLATLEY JAY TChief Executive OfficerApr 10Option Exercise20.0430,000601,200411,262Apr 11 05:15 PM
FLATLEY JAY TChief Executive OfficerApr 10Sale139.9030,0004,196,864381,262Apr 11 05:15 PM
BRADBURY DANIELDirectorApr 04Option Exercise39.142,10082,19412,024Apr 07 08:28 PM
BRADBURY DANIELDirectorApr 04Sale138.442,100290,7149,924Apr 07 08:28 PM
Ronaghi MostafaSr VP & CTOApr 01Option Exercise44.3810,000443,80038,604Apr 01 08:50 PM
Bouchard MichelChief Accounting OfficerApr 01Option Exercise69.3463143,75425,680Apr 01 08:49 PM
Ronaghi MostafaSr VP & CTOApr 01Sale152.4110,0001,524,06328,604Apr 01 08:50 PM
Bouchard MichelChief Accounting OfficerApr 01Sale150.3063194,84025,049Apr 01 08:49 PM
RASTETTER WILLIAM HDirectorMar 31Sale143.5029642,4764,168Apr 01 08:49 PM
FLATLEY JAY TChief Executive OfficerMar 27Option Exercise20.0430,000601,200411,262Mar 27 08:54 PM
FLATLEY JAY TChief Executive OfficerMar 27Sale140.1130,0004,203,370381,262Mar 27 08:54 PM
BRADBURY DANIELDirectorMar 19Option Exercise39.142,10082,19412,024Mar 19 07:52 PM
BRADBURY DANIELDirectorMar 19Sale161.142,100338,3929,924Mar 19 07:52 PM
Naclerio NicholasSr VP, Corporate & Venture DevMar 17Option Exercise43.372,00086,74025,146Mar 18 08:16 PM
MOELLER GERALDDirectorMar 17Option Exercise42.8110,000428,10024,620Mar 18 08:16 PM
Naclerio NicholasSr VP, Corporate & Venture DevMar 17Sale163.652,000327,30523,146Mar 18 08:16 PM
MOELLER GERALDDirectorMar 17Sale161.9210,0001,619,16314,620Mar 18 08:16 PM
Stapley MarcSr VP & CFOMar 14Option Exercise36.301,42251,61923,418Mar 14 07:40 PM
Stapley MarcSr VP & CFOMar 14Sale163.351,422232,27821,996Mar 14 07:40 PM
FLATLEY JAY TCEOMar 13Option Exercise20.0430,000601,200411,262Mar 13 07:34 PM
FLATLEY JAY TCEOMar 13Sale165.9630,0004,978,691381,262Mar 13 07:34 PM
HENRY CHRISTIAN OSVP, Chief Commercial OfficerMar 11Option Exercise28.453,00085,35031,519Mar 11 07:57 PM
WALT DAVID RDirectorMar 11Option Exercise3.2410,60034,344887,088Mar 12 05:30 PM
Bouchard MichelChief Accounting OfficerMar 11Sale167.212,168362,51125,049Mar 11 07:57 PM
HENRY CHRISTIAN OSVP, Chief Commercial OfficerMar 11Sale167.163,000501,47628,519Mar 11 07:57 PM
WALT DAVID RDirectorMar 10Option Exercise3.249,40030,456885,888Mar 12 05:30 PM
WALT DAVID RDirectorMar 10Sale164.209,4001,543,473876,488Mar 12 05:30 PM
Ronaghi MostafaSr VP & CTOMar 06Option Exercise44.3810,000443,80040,593Mar 10 08:30 PM
BRADBURY DANIELDirectorMar 06Option Exercise39.142,10082,19412,024Mar 10 08:30 PM